OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TGTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TGTX is expected to report earnings to rise 49.53% to 25 cents per share on October 30

TG Therapeutics TGTX Stock Earnings Reports

Q3'25

Est.

$0.25

Q2'25

Missed

by $0.02

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.07

Q3'24

Est.

$0.02

The last earnings report on August 04 showed earnings per share of 17 cents, missing the estimate of 18 cents. With 806.74K shares outstanding, the current market capitalization sits at 4.24B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TGTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TGTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TGTX showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3020 Carrington Mill boulevard

Phone

+1 212 554-4484

Employees

264

Web

https://www.tgtherapeutics.com